Dr. Ruedi Aebersold’s research focuses on developing new methods and technologies for quantitative proteomics and for applying this emerging technology to enhance our understanding of the structure, function and control of complex biological systems. Current applications of quantitative proteomics technology are directed toward discovering protein markers that differentiate cancer cells from their normal counterparts, investigating the mechanisms of fundamental cellular processes by the comparative analysis of the gene and protein expression profiles in cells at different states, and studying medical microbiology. Dr. Aebersold is a member of the editorial advisory boards of Molecular and Cellular Proteomics, Molecular Systems Biology, Journal of Proteome Research and Molecular BioSystems. He is the 2002 recipient of the Widmer Award, the ASMS Biemann Medal, and the World Technology Network Award in the biotechnology category. In November 2004, he assumed an appointment as professor of Systems Biology, Institute of Biotechnology, ETH-Zürich and faculty of natural sciences, University of Zürich. He is a professor and founding member of the Institute for Systems Biology, Seattle, Wash.